This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sambandamurthy, V. K.
Right arrow Articles by Jacobs, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sambandamurthy, V. K.
Right arrow Articles by Jacobs, W. R., Jr.

 Previous Article  |  Next Article 

Infection and Immunity, February 2005, p. 1196-1203, Vol. 73, No. 2
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.2.1196-1203.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Long-Term Protection against Tuberculosis following Vaccination with a Severely Attenuated Double Lysine and Pantothenate Auxotroph of Mycobacterium tuberculosis

Vasan K. Sambandamurthy,1,2,{dagger} Steven C. Derrick,3,{dagger} Kripa V. Jalapathy,2 Bing Chen,1,2 Robert G. Russell,4 Sheldon L. Morris,3 and William R. Jacobs Jr.1,2*

Howard Hughes Medical Institute,1 Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York,2 Department of Pathology, Lombardi Cancer Center, Georgetown University, Washington, D.C.,4 Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland3

Received 6 August 2004/ Accepted 20 September 2004

We report the safety and immunogenicity of a double lysine and pantothenate auxotroph of Mycobacterium tuberculosis in mice. The {Delta}lysA {Delta}panCD mutant is completely attenuated in immunocompromised SCID and gamma interferon knockout mice yet induces short-term and long-term protection in immunocompetent and CD4-deficient mice following single-dose subcutaneous vaccination.


* Corresponding author. Mailing address: Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2865. Fax: (718) 518-0366. E-mail: jacobsw{at}hhmi.org.

Editor: A. D. O'Brien

{dagger} V. K. Sambandamurthy and S. C. Derrick contributed equally to this work.


Infection and Immunity, February 2005, p. 1196-1203, Vol. 73, No. 2
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.2.1196-1203.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Tullius, M. V., Harth, G., Maslesa-Galic, S., Dillon, B. J., Horwitz, M. A. (2008). A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG. Infect. Immun. 76: 5200-5214 [Abstract] [Full Text]  
  • Senaratne, R. H., Mougous, J. D., Reader, J. R., Williams, S. J., Zhang, T., Bertozzi, C. R., Riley, L. W. (2007). Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. J Med Microbiol 56: 454-458 [Abstract] [Full Text]  
  • White, E. L., Southworth, K., Ross, L., Cooley, S., Gill, R. B., Sosa, M. I., Manouvakhova, A., Rasmussen, L., Goulding, C., Eisenberg, D., Fletcher, T. M. III (2007). A Novel Inhibitor of Mycobacterium tuberculosis Pantothenate Synthetase. J Biomol Screen 12: 100-105 [Abstract]  
  • Lee, S., Jeon, B.-Y., Bardarov, S., Chen, M., Morris, S. L., Jacobs, W. R. Jr. (2006). Protection Elicited by Two Glutamine Auxotrophs of Mycobacterium tuberculosis and In Vivo Growth Phenotypes of the Four Unique Glutamine Synthetase Mutants in a Murine Model.. Infect. Immun. 74: 6491-6495 [Abstract] [Full Text]  
  • Doherty, T. M., Andersen, P. (2005). Vaccines for Tuberculosis: Novel Concepts and Recent Progress. Clin. Microbiol. Rev. 18: 687-702 [Abstract] [Full Text]